DTC Marketing

Implications of headlines for DTC marketing

images
If DTC marketers don't feel that the recent rash of negative headlines (Oxy Cotin maker lied about addiction, J&J and Amgen possibly promoting higher dosing of medications) is going to effect their campaigns then they are living in a fantasy world. These stories are going to continue to chip away at the credibility of pharmaceutical companies to deliver relevant information to patients and cause more consumers to research all treatment options. Read More...
|

I'm a DTC Marketer

images
I'm a DTC marketer and proud of the job that I do. There are principles that I live by and maybe it's time for others to think about their own principles before making decisions that could impact the lives of thousands of patients. At some point in everyone's career you are going to have a draw a line in the sand for what you beleive. It could be a matter of getting a paycheck or losing a job but we all have to held accountable to the highest standard; ourselves. Here is a list of the principles which I use everyday in my career as a pharma and health DTC marketer. Read More...
|

DTC National: The blind leading the blind

images
The DTC National just wrapped up and although I didn't attend it seems that once again it's the same old show with DTC marketers. More case studies, more "we did this" and this was the result. There were some people who tried to make DTC marketers aware that the familiar landscape is changing and changing dramatically but I am sure that most of this fell on deaf ears. DTC marketers haven't yet realized that the power has shifted to consumers and that marketers messages are largely being ignored. Still with TV dying a slow death the media buyers should be thankful that there are so many stupid people in DTC marketing who continue to worship the almighty TV spots Read More...
|

Making DTC more effective, an idea...

screenshot_01
What can we do to make DTC more effective? Well let's take a category where there is intense competition, cholesterol control. Lipitor of course is the market leader and is the first $10 billion product but lately others are trying to make some inroads against the market leader. Brands like Vytorin for example are using the POD that cholesterol comes from two sources the food you eat and your family history of high cholesterol. Here is what I believe could be a very effective campaign that would require pharma companies to become collaborators for the good of patients. Read More...
|

A world without DTC

A bill currently in the house would prohibit pharma companies from doing DTC for three years after a drugs initial approval. But what are the implications of this? Far reaching I'm afraid. DTC advertising drives consumers into physicians to ask about medications and raises awareness of disease conditions that, left untreated, could lead to major health issues. Has the House and Senate thought of these issues? Of course not because it's easier to get on the bandwagon then to approach prescription drug advertising with reason and logic. Read More...
|